CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Opus Global Nyrt Company Snapshot
Opus Global Nyrt operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Opus Global Nyrt with three other pharmaceutical manufacturers in Europe: Eco Animal Health Group Plc of the United Kingdom (2016 sales of £47.14 million [US$63.61 million] of which 100% was Animal Health Product), Vistin Pharma ASA of Norway (394.03 million Norwegian Kroner [US$50.10 million] ), and Allergy Therapeutics PLC which is based in the United Kingdom (£48.51 million [US$65.46 million] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2016, sales at Opus Global Nyrt were 15.31 billion Hungarian Forints (US$58.96 million). This is an increase of 34.6% versus 2015, when the company's sales were 11.38 billion Hungarian Forints. Despite this increase, sales are still below the level achieved in 2014, when Opus Global Nyrt reported sales of 17.51 billion Hungarian Forints.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Opus Global Nyrt
  Stock Performance Chart for Opus Global Nyrt
 
  Stock Data: Recent Stock Performance:
  Current Price (9/22/2017): 207.00
(Figures in Hungarian Forints)
1 Week -1.0%   13 Weeks 3.0%  
4 Weeks 80.0%   52 Weeks 567.7%  
 
Opus Global Nyrt Key Data:
  Ticker: OPUS Country: Hungary
  Exchanges: BUD Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 15,314,717,000
(Year Ending Jan 2017).
Employees: 1,070
  Currency: Hungarian Forints Market Cap: 64,274,747,796
  Fiscal Yr Ends: December Shares Outstanding: 310,506,028
  Share Type: Namenaktie Closely Held Shares: 231,109,328
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.